OncoCyte Return on Tangible Equity 2014-2024 | OCX
Current and historical return on tangible equity values for OncoCyte (OCX) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| OncoCyte Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-03-31 | $-0.04B | $-0.05B | 145.13% |
| 2023-12-31 | $-0.03B | $-0.04B | 133.33% |
| 2023-09-30 | $-0.06B | $-0.02B | 297.44% |
| 2023-06-30 | $-0.06B | $-0.01B | 274.16% |
| 2023-03-31 | $-0.06B | $-0.02B | 237.62% |
| 2022-12-31 | $-0.07B | $-0.03B | 217.91% |
| 2022-09-30 | $-0.06B | $-0.03B | 209.84% |
| 2022-06-30 | $-0.07B | $-0.03B | 261.54% |
| 2022-03-31 | $-0.07B | $-0.05B | 297.87% |
| 2021-12-31 | $-0.06B | $-0.02B | -3657.14% |
| 2021-09-30 | $-0.03B | $-0.01B | -438.71% |
| 2021-06-30 | $-0.03B | $-0.02B | -203.77% |
| 2021-03-31 | $-0.03B | $0.05B | -125.30% |
| 2020-12-31 | $-0.03B | $0.01B | -260.87% |
| 2020-09-30 | $-0.03B | $0.01B | -188.24% |
| 2020-06-30 | $-0.03B | $0.02B | -137.93% |
| 2020-03-31 | $-0.03B | $0.01B | -98.11% |
| 2019-12-31 | $-0.02B | $0.03B | -66.67% |
| 2019-09-30 | $-0.02B | $0.03B | -73.08% |
| 2019-06-30 | $-0.02B | $0.03B | -81.93% |
| 2019-03-31 | $-0.02B | $0.04B | -121.43% |
| 2018-12-31 | $-0.02B | $0.00B | -261.54% |
| 2018-09-30 | $-0.02B | $0.01B | -237.04% |
| 2018-06-30 | $-0.02B | $0.01B | -307.69% |
| 2018-03-31 | $-0.02B | $0.01B | -316.67% |
| 2017-12-31 | $-0.02B | $0.00B | -333.33% |
| 2017-09-30 | $-0.02B | $0.01B | -262.07% |
| 2017-06-30 | $-0.02B | $0.01B | -176.47% |
| 2017-03-31 | $-0.01B | $0.01B | -175.00% |
| 2016-12-31 | $-0.01B | $0.01B | -160.00% |
| 2016-09-30 | $-0.01B | $0.01B | -173.33% |
| 2016-06-30 | $-0.01B | $0.00B | -266.67% |
| 2016-03-31 | $-0.01B | $0.01B | -266.67% |
| 2015-12-31 | $-0.01B | $0.01B | -355.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.023B | $0.002B |
| OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $124.209B | 15.59 |
| Cencora (COR) | United States | $47.206B | 18.40 |
| ICON (ICLR) | Ireland | $26.298B | 24.83 |
| DiDi Global (DIDIY) | China | $21.580B | 0.00 |
| Avantor (AVTR) | United States | $15.025B | 22.12 |
| CochLear (CHEOY) | Australia | $14.104B | 0.00 |
| Revvity (RVTY) | United States | $13.324B | 23.37 |
| Natera (NTRA) | United States | $13.153B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.518B | 41.19 |
| Viatris (VTRS) | United States | $12.466B | 3.73 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $10.906B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.900B | 20.87 |
| Solventum (SOLV) | United States | $9.041B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.666B | 0.00 |
| HealthEquity (HQY) | United States | $7.278B | 46.73 |
| Organon (OGN) | United States | $5.359B | 5.08 |
| Bausch + Lomb (BLCO) | Canada | $5.253B | 21.03 |
| Doximity (DOCS) | United States | $5.103B | 35.74 |
| PACS (PACS) | United States | $4.437B | 0.00 |
| Life Times (LTH) | United States | $3.659B | 38.33 |
| Sotera Health (SHC) | United States | $3.400B | 16.68 |
| Surgery Partners (SGRY) | United States | $3.113B | 28.48 |
| GoodRx Holdings (GDRX) | United States | $2.900B | 110.43 |
| Agilon Health (AGL) | United States | $2.681B | 0.00 |
| Progyny (PGNY) | United States | $2.462B | 42.39 |
| NovoCure (NVCR) | Jersey | $2.052B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.013B | 7.98 |
| Premier (PINC) | United States | $1.950B | 8.34 |
| BrightSpring Health Services (BTSG) | United States | $1.819B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.647B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.566B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.388B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.141B | 0.00 | |
| CareDx (CDNA) | United States | $0.732B | 0.00 |
| Embecta (EMBC) | United States | $0.721B | 4.91 |
| GeneDx Holdings (WGS) | United States | $0.717B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.673B | 7.14 |
| InnovAge Holding (INNV) | United States | $0.646B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.599B | 0.00 |
| Sharecare (SHCR) | United States | $0.497B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.437B | 11.45 |
| Enhabit (EHAB) | United States | $0.428B | 42.70 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.427B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| ModivCare (MODV) | United States | $0.368B | 6.88 |
| DocGo (DCGO) | United States | $0.314B | 17.17 |
| LifeMD (LFMD) | United States | $0.289B | 0.00 |
| MultiPlan (MPLN) | United States | $0.236B | 0.00 |
| Beauty Health (SKIN) | United States | $0.221B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.217B | 0.00 |
| Biodesix (BDSX) | United States | $0.196B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.189B | 0.00 |
| So-Young (SY) | China | $0.108B | 52.00 |
| Pono Capital Two (PTWO) | United States | $0.068B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.046B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 5.72 |
| IceCure Medical (ICCM) | Israel | $0.034B | 0.00 |
| Oncology Institute (TOI) | United States | $0.033B | 0.00 |
| Nutex Health (NUTX) | United States | $0.028B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.026B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.022B | 0.00 |
| KindlyMD (KDLY) | $0.017B | 0.00 | |
| BIMI Holdings (BIMI) | United States | $0.015B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| DermTech (DMTK) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.004B | 0.00 |
| OpGen (OPGN) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Assure Holdings (IONM) | United States | $0.002B | 0.00 |